520 related articles for article (PubMed ID: 27064363)
1. Histone deacetylase inhibitors decrease NHEJ both by acetylation of repair factors and trapping of PARP1 at DNA double-strand breaks in chromatin.
Robert C; Nagaria PK; Pawar N; Adewuyi A; Gojo I; Meyers DJ; Cole PA; Rassool FV
Leuk Res; 2016 Jun; 45():14-23. PubMed ID: 27064363
[TBL] [Abstract][Full Text] [Related]
2. Increasing CRISPR/Cas9-mediated homology-directed DNA repair by histone deacetylase inhibitors.
Li G; Zhang X; Wang H; Liu D; Li Z; Wu Z; Yang H
Int J Biochem Cell Biol; 2020 Aug; 125():105790. PubMed ID: 32534122
[TBL] [Abstract][Full Text] [Related]
3. Common and unique genetic interactions of the poly(ADP-ribose) polymerases PARP1 and PARP2 with DNA double-strand break repair pathways.
Ghosh R; Roy S; Kamyab J; Danzter F; Franco S
DNA Repair (Amst); 2016 Sep; 45():56-62. PubMed ID: 27373144
[TBL] [Abstract][Full Text] [Related]
4. The absence of Ku but not defects in classical non-homologous end-joining is required to trigger PARP1-dependent end-joining.
Mansour WY; Borgmann K; Petersen C; Dikomey E; Dahm-Daphi J
DNA Repair (Amst); 2013 Dec; 12(12):1134-42. PubMed ID: 24210699
[TBL] [Abstract][Full Text] [Related]
5. Nuclear PTEN interferes with binding of Ku70 at double-strand breaks through post-translational poly(ADP-ribosyl)ation.
Guan J; Zhao Q; Mao W
Biochim Biophys Acta; 2016 Dec; 1863(12):3106-3115. PubMed ID: 27741411
[TBL] [Abstract][Full Text] [Related]
6. Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias.
Tobin LA; Robert C; Rapoport AP; Gojo I; Baer MR; Tomkinson AE; Rassool FV
Oncogene; 2013 Apr; 32(14):1784-93. PubMed ID: 22641215
[TBL] [Abstract][Full Text] [Related]
7. Ku counteracts mobilization of PARP1 and MRN in chromatin damaged with DNA double-strand breaks.
Cheng Q; Barboule N; Frit P; Gomez D; Bombarde O; Couderc B; Ren GS; Salles B; Calsou P
Nucleic Acids Res; 2011 Dec; 39(22):9605-19. PubMed ID: 21880593
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9-Induced Double-Strand Break Repair in Arabidopsis Nonhomologous End-Joining Mutants.
Shen H; Strunks GD; Klemann BJ; Hooykaas PJ; de Pater S
G3 (Bethesda); 2017 Jan; 7(1):193-202. PubMed ID: 27866150
[TBL] [Abstract][Full Text] [Related]
9. Sp1-dependent recruitment of the histone acetylase p300 to DSBs facilitates chromatin remodeling and recruitment of the NHEJ repair factor Ku70.
Swift ML; Beishline K; Azizkhan-Clifford J
DNA Repair (Amst); 2021 Sep; 105():103171. PubMed ID: 34252870
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitors selectively target homology dependent DNA repair defective cells and elevate non-homologous endjoining activity.
Smith S; Fox J; Mejia M; Ruangpradit W; Saberi A; Kim S; Choi Y; Oh S; Wang Y; Choi K; Li L; Hendrickson EA; Takeda S; Muller M; Myung K
PLoS One; 2014; 9(1):e87203. PubMed ID: 24466340
[TBL] [Abstract][Full Text] [Related]
11. PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways.
Wang M; Wu W; Wu W; Rosidi B; Zhang L; Wang H; Iliakis G
Nucleic Acids Res; 2006; 34(21):6170-82. PubMed ID: 17088286
[TBL] [Abstract][Full Text] [Related]
12. PARP1 Links CHD2-Mediated Chromatin Expansion and H3.3 Deposition to DNA Repair by Non-homologous End-Joining.
Luijsterburg MS; de Krijger I; Wiegant WW; Shah RG; Smeenk G; de Groot AJL; Pines A; Vertegaal ACO; Jacobs JJL; Shah GM; van Attikum H
Mol Cell; 2016 Feb; 61(4):547-562. PubMed ID: 26895424
[TBL] [Abstract][Full Text] [Related]
13. Class I histone deacetylase inhibitors inhibit the retention of BRCA1 and 53BP1 at the site of DNA damage.
Fukuda T; Wu W; Okada M; Maeda I; Kojima Y; Hayami R; Miyoshi Y; Tsugawa K; Ohta T
Cancer Sci; 2015 Aug; 106(8):1050-6. PubMed ID: 26053117
[TBL] [Abstract][Full Text] [Related]
14. Histone acetylation by CBP and p300 at double-strand break sites facilitates SWI/SNF chromatin remodeling and the recruitment of non-homologous end joining factors.
Ogiwara H; Ui A; Otsuka A; Satoh H; Yokomi I; Nakajima S; Yasui A; Yokota J; Kohno T
Oncogene; 2011 May; 30(18):2135-46. PubMed ID: 21217779
[TBL] [Abstract][Full Text] [Related]
15. CHD7 and 53BP1 regulate distinct pathways for the re-ligation of DNA double-strand breaks.
Rother MB; Pellegrino S; Smith R; Gatti M; Meisenberg C; Wiegant WW; Luijsterburg MS; Imhof R; Downs JA; Vertegaal ACO; Huet S; Altmeyer M; van Attikum H
Nat Commun; 2020 Nov; 11(1):5775. PubMed ID: 33188175
[TBL] [Abstract][Full Text] [Related]
16. Regulation of DNA repair in the absence of classical non-homologous end joining.
Kang YJ; Yan CT
DNA Repair (Amst); 2018 Aug; 68():34-40. PubMed ID: 29929045
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation.
Chen CS; Wang YC; Yang HC; Huang PH; Kulp SK; Yang CC; Lu YS; Matsuyama S; Chen CY; Chen CS
Cancer Res; 2007 Jun; 67(11):5318-27. PubMed ID: 17545612
[TBL] [Abstract][Full Text] [Related]
18. Parp1-XRCC1 and the repair of DNA double strand breaks in mouse round spermatids.
Ahmed EA; de Boer P; Philippens ME; Kal HB; de Rooij DG
Mutat Res; 2010 Jan; 683(1-2):84-90. PubMed ID: 19887075
[TBL] [Abstract][Full Text] [Related]
19. Hyper-active non-homologous end joining selects for synthetic lethality resistant and pathological Fanconi anemia hematopoietic stem and progenitor cells.
Du W; Amarachintha S; Wilson AF; Pang Q
Sci Rep; 2016 Feb; 6():22167. PubMed ID: 26916217
[TBL] [Abstract][Full Text] [Related]
20. Combination of a hypomethylating agent and inhibitors of PARP and HDAC traps PARP1 and DNMT1 to chromatin, acetylates DNA repair proteins, down-regulates NuRD and induces apoptosis in human leukemia and lymphoma cells.
Valdez BC; Li Y; Murray D; Liu Y; Nieto Y; Champlin RE; Andersson BS
Oncotarget; 2018 Jan; 9(3):3908-3921. PubMed ID: 29423093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
